The FDAs greenlight was supported by data from the Phase III MANDARA trial, which set Fasenra against GSKs Nucala, previously the only approved treatment for EGPA
Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis
Traditional Cardiovascular Drugs Peptides are not designed to replace medications like ACE inhibitors, ARBs, or statinsbut to complement or even reduce dependence on them over time
Figure 1 Intriguingly, several key pathological features of PD align remarkably with the triggers and hallmarks of ferroptosis, including amplified lipid peroxidation, increased iron accumulation, suppressed expression of the cysteine-glutamate antiporter (system Xc - ) and diminished glutathione (GSH) levels ( SNCA triplication neurons is approximately 1.5-fold higher than that in control neurons, and exposure to 10 nM -syn oligomers further elevates lipid peroxidation levels ( Consequently, exploring ferroptosis as a pivotal mechanism in dopaminergic neuron demise offers promising avenues for novel therapeutic interventions in PD
Dosing frequency: IV sessions are typically weekly or biweekly
